InvestorsHub Logo

TJG

Followers 604
Posts 27484
Boards Moderated 2
Alias Born 06/20/2007

TJG

Re: TJG post# 5014

Monday, 04/01/2024 8:32:55 AM

Monday, April 01, 2024 8:32:55 AM

Post# of 6598
Nothing worth getting excited about in the PR just released... no real update on the Phase III just this statement


Top line results expected forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea

Add that to the fact that they lost money in for the year 2023 compared to the year 2022,

Net Q4 2023 revenue of approximately $2.3 million decreased 18% versus net Q3 2023 revenue of $2.8 million and decreased approximately 30% versus net Q4 2022 revenue of $3.3 million

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-reports-2023-financial-results

So where is this headed... maybe when Loser Lisa starts babbling on she will give some clarification as to what can be expected

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News